myxedema; thyroid dermopathy (includes myxedema coma)
Jump to navigation
Jump to search
Introduction
Hypothyroidism which first appears in older children or adults
Etiology
- removal or loss of functioning thyroid tissue
- pretibial myxedema nearly always associated with Graves disease[5]
- tobacco use may increase risk of pretibial myxedema[3]
- less frequently occurs with Hashimoto's thyroiditis[7]
Pathology
- accumulation of mucopolysaccharides (hyaluronic acid) in connective tissue throughout the body leads to skin changes & non-pitting edema
* histopathology images[5][6]
Clinical manifestations
- relatively hard, not-pitting edema of the subcutaneous tissue
- most often confined to the pretibial area (pretibial myxedema)
- firm, but compressible indurated woody plaques
- occurs 1-2 years after onset of Graves disease[2]
- some patients may develop elephantiasis[3]
- dryness & loss of hair
- subnormal temperature
- hoarseness
- muscle weakness, fatigue
- slow return of a muscle after a tendon jerk to the neutral position
- cognitive impairment: confusion, disorientation[4]
* pretibial myxedema images[5][6][8]
Laboratory
- thyroid function tests
- serum TSH is high* ' - serum thyroxine is low*
- serum sodium: hypnoatremia* (generally not severe)
* exception is pretibial myxedema of Graves disease
- values dependent upon treatment status
Management
- primary therapy is thyroxine* (T4)
- treatment is often administered intravenously, since there may be edema of the gut wall that limits oral absorption[4]
- treatment with T3 (Cytomel) is controversial
- treat underlying precipitating factors
- topical glucocorticoid[6]
- compression stockings[6]
- smoking cessation[3]
* exception is pretibial myxedema of Graves disease
More general terms
More specific terms
References
- ↑ Stedman's Medical Dictionary 24th ed, Williams & Wilkins, Baltimore, 1982
- ↑ 2.0 2.1 Cotran et al Robbins Pathologic Basis of Disease, 5th ed. W.B. Saunders Co, Philadelphia, PA 1994 pg 1125-26
- ↑ 3.0 3.1 3.2 3.3 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17. American College of Physicians, Philadelphia 2009, 2012, 2015
- ↑ 4.0 4.1 4.2 Kim J Myxedema N Engl J Med 2015; 372:764. February 19, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25693016 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMicm1403210
- ↑ 5.0 5.1 5.2 5.3 vonHilsheimer GE, Elston DM Medscape: Pretibial Myxedema http://emedicine.medscape.com/article/1103765-overview
- ↑ 6.0 6.1 6.2 6.3 6.4 DermNet NZ: Pretibial myxoedema (images) http://www.dermnetnz.org/dermal-infiltrative/pretibial-myxoedema.html
- ↑ 7.0 7.1 Fatourechi V Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6(5):295-309. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16252929
- ↑ 8.0 8.1 Xie F, Johnson EF, Youssef MJ Thyroid Dermopathy and Acropachy Mayo Clinic Proceedings, 2022. 97(12):2314-15 https://www.mayoclinicproceedings.org/article/S0025-6196(22)00469-4/fulltext
- ↑ Wikipedia: Myxedema https://en.wikipedia.org/wiki/Myxedema